Trials / Completed
CompletedNCT00881231
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Eon and Otsuka (Pletal) 50 mg Cilostazol Tablets In Healthy Adults Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA) | |
| DRUG | Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA) |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2004-02-01
- Completion
- 2004-02-01
- First posted
- 2009-04-15
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00881231. Inclusion in this directory is not an endorsement.